UCB SA (UCB) - Total Liabilities

Latest as of December 2025: €7.29 Billion EUR ≈ $8.52 Billion USD

Based on the latest financial reports, UCB SA (UCB) has total liabilities worth €7.29 Billion EUR (≈ $8.52 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore UCB SA (UCB) equity growth momentum to track the company's year-over-year net asset growth rate.

UCB SA - Total Liabilities Trend (2000–2025)

This chart illustrates how UCB SA's total liabilities have evolved over time, based on quarterly financial data. See UCB cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

UCB SA Competitors by Total Liabilities

The table below lists competitors of UCB SA ranked by their total liabilities.

Company Country Total Liabilities
Exelon Corporation
NASDAQ:EXC
USA $88.23 Billion
Hangzhou Hikvision Digital Technology Co Ltd
SHE:002415
China CN¥40.94 Billion
E.ON SE
F:EOAN
Germany €84.85 Billion
E.ON SE
F:EOAA
Germany €84.85 Billion
Diageo plc
MX:DEON
Mexico MX$36.58 Billion
Sandvik AB
ST:SAND
Sweden Skr81.89 Billion
Bank Central Asia Tbk
JK:BBCA
Indonesia Rp1242.32 Trillion
Orange S.A.
PA:ORA
France €82.15 Billion

Liability Composition Analysis (2000–2025)

This chart breaks down UCB SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see UCB stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.38 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.67 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.40 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how UCB SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for UCB SA (2000–2025)

The table below shows the annual total liabilities of UCB SA from 2000 to 2025.

Year Total Liabilities Change
2025-12-31 €7.29 Billion
≈ $8.52 Billion
-0.37%
2024-12-31 €7.32 Billion
≈ $8.56 Billion
+11.49%
2023-12-31 €6.56 Billion
≈ $7.67 Billion
-3.53%
2022-12-31 €6.80 Billion
≈ $7.95 Billion
+16.83%
2021-12-31 €5.82 Billion
≈ $6.81 Billion
-3.69%
2020-12-31 €6.05 Billion
≈ $7.07 Billion
+48.50%
2019-12-31 €4.07 Billion
≈ $4.76 Billion
-4.39%
2018-12-31 €4.26 Billion
≈ $4.98 Billion
+1.87%
2017-12-31 €4.18 Billion
≈ $4.89 Billion
-11.70%
2016-12-31 €4.74 Billion
≈ $5.54 Billion
-12.48%
2015-12-31 €5.41 Billion
≈ $6.32 Billion
+2.89%
2014-12-31 €5.26 Billion
≈ $6.15 Billion
-3.29%
2013-12-31 €5.44 Billion
≈ $6.36 Billion
+14.05%
2012-12-31 €4.77 Billion
≈ $5.57 Billion
+9.46%
2011-12-31 €4.36 Billion
≈ $5.09 Billion
-0.50%
2010-12-31 €4.38 Billion
≈ $5.12 Billion
-6.93%
2009-12-31 €4.70 Billion
≈ $5.50 Billion
-14.60%
2008-12-31 €5.51 Billion
≈ $6.44 Billion
+4.08%
2007-12-31 €5.29 Billion
≈ $6.19 Billion
-7.50%
2006-12-31 €5.72 Billion
≈ $6.69 Billion
+147.83%
2005-12-31 €2.31 Billion
≈ $2.70 Billion
-32.29%
2004-12-31 €3.41 Billion
≈ $3.98 Billion
+160.76%
2003-12-31 €1.31 Billion
≈ $1.53 Billion
+23.83%
2002-12-31 €1.06 Billion
≈ $1.23 Billion
-10.05%
2001-12-31 €1.17 Billion
≈ $1.37 Billion
+6.95%
2000-12-31 €1.10 Billion
≈ $1.28 Billion
--

About UCB SA

BR:UCB Belgium Biotechnology
Market Cap
$54.15 Billion
€46.31 Billion EUR
Market Cap Rank
#564 Global
#3 in Belgium
Share Price
€243.30
Change (1 day)
-0.25%
52-Week Range
€178.15 - €285.40
All Time High
€285.40
About

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company offers Cimzia for ankylosing spondylitis (AS), axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, polyarticular juvenile idiopathic arthritis, and rheumatoid arthritis; Vimpat, Keppra, … Read more